BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 56 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $95,000 | -4.0% | 63,075 | +23.3% | 0.00% | 0.0% |
Q4 2015 | $99,000 | -2.0% | 51,175 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $101,000 | -4.7% | 51,175 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $106,000 | -10.2% | 51,175 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $118,000 | +2.6% | 51,175 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $115,000 | +42.0% | 51,175 | +57.0% | 0.00% | – |
Q3 2014 | $81,000 | +24.6% | 32,594 | +43.2% | 0.00% | – |
Q2 2014 | $65,000 | -50.4% | 22,761 | +6.6% | 0.00% | -100.0% |
Q1 2014 | $131,000 | -17.1% | 21,361 | -43.3% | 0.00% | 0.0% |
Q4 2013 | $158,000 | +0.6% | 37,661 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $157,000 | +20.8% | 37,661 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $130,000 | – | 37,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
BVF INC/IL | 435,900 | $976,000 | 0.19% |
Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |